Identifies a likely endoperoxide intermediate in prostaglandin biosynthesis that may act as a trigger for the platelet release reaction.
Answers are grounded in this paper and cite their sources.
May implicate endoperoxides in platelet release; hypothesis-generating for prostaglandin pathways in thrombosis.
A compound that could be converted to prostaglandin F(2alpha) by mild chemical reduction was formed by human platelets in response to arachidonic acid, collagen, or L-epinephrine. It was present in maximal amounts at about 1 min after addition of arachidonic acid or collagen to platelet-rich plasma. Its initial formation appeared to precede platelet aggregation by these agents and was closely correlated with the release of adenine nucleotides and radioactive 5-hydroxytryptamine from platelets. Moreover, the compound was itself found outside the platelets. This compound is probably an endoperoxide intermediate in prostaglandin biosynthesis and may be a trigger for the platelet release reaction.
No takes yet. Share an insight, caveat, or question.
Smith et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: